Health Care · Pharmaceutical Preparations · Nasdaq · CIK 1173313 · FYE Dec 31 · Prices AT CLOSE 2026-07-29 (USD) — end-of-day, never a live or intraday quote
Last $1.01Day −4.72%Mkt cap $26M1Y −66.1%Off 52W high −70.3%Vol (1Y) 86.8%
Daily closing price, split-adjusted to the current basis; 3y shown of 1,849 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest1.8% of sh out |
| Days to cover1.8d |
| 13F net flow (QoQ)+0.00% |
| Top-10 13F concentration99.1% |
| Next report (est.)2026-08-18 |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Sales (TTM)$296,000 |
| Earnings (TTM)-$8.6M |
| ROE−128.2% |
| Net margin−2671.8% |
| ROIC−87.2% |
| Sales growth 3Y−32.7% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD−52.6% |
| 1Y−66.1% |
| 3Y−59.4% |
| 5Y−97.7% |
| Since incept. (ann.)−26.6% |
Total return through 2026-07-29 · series begins 2016-12-07. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)86.8% |
| Ann. volatility (3Y)119.4% |
| Sharpe (1Y)−0.84 |
| Sharpe (3Y)0.29 |
| Max drawdown (1Y)−72.4% |
| Max drawdown (3Y)−88.4% |
| Beta (3Y vs SPY)1.04 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | 221,169 | $214,598 | 0.87% | +9.3% |
| VANGUARD CAPITAL MANAGEMENT LLC | 190,574 | $184,857 | 0.75% | new |
| VANGUARD FIDUCIARY TRUST CO | 97,363 | $94,442 | 0.38% | new |
| RENAISSANCE TECHNOLOGIES LLC | 95,100 | $92,257 | 0.37% | −16.8% |
| STATE STREET CORP | 72,800 | $70,623 | 0.29% | +0.0% |
| BlackRock, Inc. | 56,442 | $54,754 | 0.22% | +0.0% |
| NORTHERN TRUST CORP | 32,087 | $31,128 | 0.13% | +0.0% |
| TWO SIGMA SECURITIES, LLC | 21,023 | $20,394 | 0.08% | new |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-05-18 | −$0.06 | — | — | — |
| 2025-09-30 | 2025-11-03 | −$0.09 | — | $795,950 | +104.5% |
| 2025-06-30 | 2025-08-13 | −$0.13 | — | — | — |
| 2025-03-31 | 2025-04-15 | −$0.06 | — | — | — |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-08-18 is ESTIMATED from filing cadence (median gap 92d) — not company-confirmed.
